These Alzheimer’s drugs were supposed to revolutionize the way we fight the disease. The reality is more complicated.
A scientific report has raised questions about how much Leqimbi and Kisunla — the “breakthrough” Alzheimer’s drugs that have hit…
A scientific report has raised questions about how much Leqimbi and Kisunla — the “breakthrough” Alzheimer’s drugs that have hit…
It’s “a move away from a one-size-fits-all framework for Alzheimer’s disease.” www.marketwatch.com #Alzheimers #affects #men #womens #brains #differently #research #shows…
The AI healthcare pivot inside the OpenAI Foundation became concrete this week as the organization announced it is finalizing more…
“My husband’s memory is still good, but he has lost some executive function.” www.marketwatch.com #feel #pressured #husband #early #Alzheimers #visit…
Biogen Inc. (NASDAQ:BIIB) on Friday reported better-than-expected fourth-quarter earnings, with adjusted EPS of $1.99, beating the consensus of $1.59. The…
Chris Hemsworth told The Guardian in a new interview on his “Crime 101” press tour that he had some reservations…
Fergus WalshMedical editor BBC Dr Michael Sandberg, whose mother had Alzheimer’s disease, took part in the trial An international trial…
“I’m retired and 72.” www.marketwatch.com #absolutely #idea #diagnosed #Alzheimers #disease #inherited #400K #invest
James GallagherHealth and science correspondent James Gallagher James Gallagher, health and science correspondent Is curing Alzheimer’s disease an impossible challenge…
Madison Muller, Bloomberg News health reporter, says that the failure of a long-shot trial to see if the pill form…